Valuation : Zenotech Laboratories Limited

Market Cap 209.27Cr 2.2Cr 1.9Cr 1.79Cr 1.63Cr 3.06Cr 3.08Cr 21Cr 8.23Cr 106.39Cr 8.28Cr 8.1Cr 353.19Cr P/E 2024
43.5x
P/E 2025 56.5x
Enterprise Value 182.57Cr 1.92Cr 1.66Cr 1.56Cr 1.42Cr 2.67Cr 2.69Cr 18Cr 7.18Cr 93Cr 7.22Cr 7.06Cr 308.12Cr EV / Sales 2024
9.27x
EV / Sales 2025 7.42x
Free-Float
15.47%
Yield 2024 *
-
Yield 2025 -
28/07 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
29/04 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
23/01 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
23/01 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
31/25/31 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25/25/25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
28/25/28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/25/30 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
28/25/28 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
23/24/23 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
23/24/23 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
26/24/26 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
17/24/17 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day+0.32%
1 week+1.98%
Current month+0.32%
1 month+4.18%
3 months+3.62%
6 months+2.84%
Current year+0.45%
1 week 44.71
Extreme 44.71
50
1 month 43
Extreme 43
50
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
57.9
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 23/10/2024
Director of Finance/CFO - 06/02/2014
Compliance Officer 46 11/03/2016
Director TitleAgeSince
Director/Board Member 58 08/07/2015
Chairman 67 -
Director/Board Member 42 27/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.32%+1.98%-16.76%-14.41% 2.97Cr
+0.28%-6.97%+58.34%+109.31% 1,03100Cr
+2.01%-0.68%+53.07%+67.73% 64TCr
+1.39%-1.71%+23.57%+76.91% 45TCr
-1.50%-6.18%+33.50%+33.50% 35TCr
+6.25%+3.31%+29.46%+46.64% 29TCr
-0.07%-1.22%+1.46%+12.19% 25TCr
+1.92%-1.29%+52.28%+70.91% 23TCr
+0.51%-1.79%-18.09%-53.86% 20TCr
+2.45%+2.17%+32.71%+96.03% 18TCr
Average +1.16%-2.52%+24.95%+44.50% 36.3TCr
Weighted average by Cap. +1.00%-3.97%+38.53%+66.75%

Financials

2024 2025
Net sales 37Cr 38.77L 33.43L 31.46L 28.69L 53.88L 54.25L 3.73Cr 1.45Cr 19Cr 1.46Cr 1.42Cr 62Cr 39Cr 41.18L 35.51L 33.42L 30.47L 57.23L 57.62L 3.96Cr 1.54Cr 20Cr 1.55Cr 1.51Cr 66Cr
Net income 8.3Cr 9L 8L 7L 6L 12.15L 12.23L 84.06L 32.64L 4.22Cr 32.82L 32.1L 14Cr 5.61Cr 6L 5L 5L 4L 8L 8L 56.86L 22.08L 2.85Cr 22.2L 21.71L 9.47Cr
Net Debt -20Cr -20.74L -17.88L -16.83L -15.34L -28.82L -29.02L -1.99Cr -77.44L -10Cr -77.86L -76.16L -33Cr -27Cr -28.13L -24.26L -22.83L -20.81L -39.09L -39.36L -2.7Cr -1.05Cr -14Cr -1.06Cr -1.03Cr -45Cr
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
228
Date Price Change Volume
01/26/01 ₹46.40 +0.32% 2,395
31/26/31 ₹46.25 -1.47% 4,980
28/26/28 ₹46.94 +4.13% 41,762
27/26/27 ₹45.08 -0.49% 9,736
26/26/26 ₹45.30 -0.96% 8,916
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock